Interplay of Tumor Microenvironment and MUC4 in Pancreatic Cancer
Interplay of Tumor Microenvironment and MUC4 in Pancreatic Cancer
批准号:
8566911
负责人:
Surinder K. Batra
金额:
$31.02万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2016-07-31
关键词:
Animal ModelAnimalsCancer cell lineCell LineCellsClinicalCuesDevelopmentDrug resistanceDuctal Epithelial CellEarly DiagnosisEnvironmentEnzymesEventExtracellular MatrixGenesHumanImmuneIn VitroInflammationInflammatoryInterferonsInterleukin-1Interleukin-12Knock-in MouseLaboratoriesLesionLightMUC4 mucinMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMediator of activation proteinNCOA3 geneNeoplasm MetastasisPancreasPancreatitisRegulationRetinoic Acid ReceptorSamplingStagingTissuesTransgenic OrganismsTretinoinTumorigenicityUp-RegulationValidationcancer riskcell motilitychromatin remodelingcytokinein vivoknockout animalmouse modelmutantneoplasticneoplastic celloutcome forecastoverexpressionpancreatic cancer cellspancreatic neoplasmresponsetumortumor microenvironmenttumor progression
中文摘要
胰腺癌中肿瘤微环境和MUC 4的相互作用
临床上,MUC 4粘蛋白在胰腺癌(PC)组织中异常过表达,并且其表达在胰腺癌组织中异常表达。
与预后不良有关(1)。我们实验室的研究最终确定MUC 4是
参与增强体外肿瘤细胞的运动性、侵袭性和耐药性,
体内致瘤性和转移(2)。MUC 4上调是胰腺癌的早期事件之一,
通过其在前驱病变中的上调来指示(3)。我们以前的研究表明MUC 4
在胰腺癌细胞中的表达部分受到细胞因子如IFN-γ的调节,
由肿瘤细胞/发炎的胰腺微环境。炎症被认为是癌症的前兆,
在胰腺癌的情况下,越来越多的证据支持胰腺炎与胰腺癌之间的关联,
癌症风险/发展强调了炎症在这种致命恶性肿瘤中的重要性。因此不
令人惊讶的是,与高MUC 4水平一样,肿瘤中高水平的促炎细胞因子(IL-1和IL-12)也是如此。
与预后不良相关(4)。鉴于炎症的重要性和MUC 4的参与,
胰腺癌的发展,以及炎症细胞因子如IFN-γ对MUC 4的调节,
该建议的目的是了解肿瘤对MUC 4表达的调节,
MUC 4和肿瘤微环境的另一个方面是MUC 4相互作用的能力,
与细胞外基质的成分,并可能通过独特的结构域(NIDO)调节。但要
保持提案的重点,避免与我们正在进行的研究重叠,即当前申请的重点
肿瘤微环境(TME)对MUC 4的调控。
英文摘要
Interplay of tumor microenvironment and MUC4 in pancreatic cancer.
Clinically, MUC4 mucin is aberrantly overexpressed in pancreatic cancer (PC) tissues and its expression is
associated with poor prognosis (1). Studies from our laboratory have conclusively established that MUC4 is
involved in enhanced motility, invasiveness and drug resistance of tumor cells in vitro and promotes
tumorigenicity and metastasis in vivo (2). MUC4 upregulation is one of the early events in pancreatic cancer as
indicated by its upregulation in precursor lesions (3). Our previous studies have demonstrated that MUC4
expression in pancreatic cancer cells in part is regulated by cytokines like IFN- y which are potentially secreted
by cells of tumor/inflamed pancreas microenvironment. Inflammation is regarded as a precursor to cancer and
in case of pancreatic cancer the increasing evidence supporting the association of pancreatitis to pancreatic
cancer risk/development underscores the importance of inflammation in this lethal malignancy. It is thus not
surprising that like high MUC4 levels, high levels of pro-inflammatory cytokines (IL-1 & IL-12) in tumor
correlates with poor prognosis (4). Given the importance of inflammation and involvement of MUC4 in
pancreatic cancer development, and regulation of MUC4 by inflammatory cytokines like IFN- y, the overall
objective of this proposal is to understand the modulation of MUC4 expression by tumor
microenvironment Another aspect of MUC4 and tumor microenvironment is the ability of MUC4 to interact
with and possibly modulate the components of extracellular matrix via the unique domain (NIDO). However, to
keep the proposal focused and avoid overlap with our ongoing studies the emphasis of the current application
is on the regulation of MUC4 by tumor microenvironment (TME).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
-
批准号:10683305
-
项目类别:
-
资助金额:$50.35万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer
-
批准号:10557180
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Novel Therapy to Inhibit IPMN Progression
-
批准号:10446455
-
项目类别:
-
资助金额:$68.62万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer
-
批准号:10367553
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Novel Therapy to Inhibit IPMN Progression
-
批准号:10640955
-
项目类别:
-
资助金额:$65.59万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Connectivity mapping identified novel combination therapy for glioblastoma
-
批准号:10504826
-
项目类别:
-
资助金额:$44.59万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Connectivity mapping identified novel combination therapy for glioblastoma
-
批准号:10686268
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
-
批准号:10503433
-
项目类别:
-
资助金额:$52.69万
-
财政年份:2022
-
负责人:Surinder K. Batra
-
依托单位:
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
-
批准号:10156494
-
项目类别:
-
资助金额:$63.74万
-
财政年份:2021
-
负责人:Surinder K. Batra
-
依托单位:
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
-
批准号:10339431
-
项目类别:
-
资助金额:$62.64万
-
财政年份:2021
-
负责人:Surinder K. Batra
-
依托单位:
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
-
批准号:10551280
-
项目类别:
-
资助金额:$62.24万
-
财政年份:2021
-
负责人:Surinder K. Batra
-
依托单位:
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
-
批准号:10543148
-
项目类别:
-
资助金额:$53.54万
-
财政年份:2019
-
负责人:Surinder K. Batra
-
依托单位:
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
-
批准号:9917334
-
项目类别:
-
资助金额:$61.45万
-
财政年份:2019
-
负责人:Surinder K. Batra
-
依托单位:
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
-
批准号:10308404
-
项目类别:
-
资助金额:$53.54万
-
财政年份:2019
-
负责人:Surinder K. Batra
-
依托单位:
Core 1: Administrative and Bioinformatics Core
-
批准号:10413941
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
Pancreatic Cancer Metastasis
-
批准号:10413937
-
项目类别:
-
资助金额:$161.14万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis
-
批准号:10413938
-
项目类别:
-
资助金额:$30.89万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
Pancreatic Cancer Metastasis
-
批准号:10203861
-
项目类别:
-
资助金额:$164.43万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis
-
批准号:10203862
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
Core 1: Administrative and Bioinformatics Core
-
批准号:10203865
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2018
-
负责人:Surinder K. Batra
-
依托单位:
海外基金